World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

Nasser Institute For Research and Treatment35 enrolled

Overview

Objectives: identify and recognize clinical Characteristics, Pathophysiology, and management of a group of patients with rhino Rhino-Orbito-Cerebral Mucormycosis infection associated with Covid 19 viral infection

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Mucormycosis; Rhinocerebral (Etiology)COVID-19

Interventions

debridmentPROCEDURE

resection of dead bone

Eligibility

Sex: ALLMin age: 22 YearsMax age: 77 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * all patients with mucormycosis post covid 19 Exclusion Criteria: * The patient not suffered from covid 19

Locations (1)

Omar Elmonofy

Cairo, Egypt

Outcomes

Primary Outcomes

35 patients suffering from mucormycosis infection post covid 19

Ratio Scale. Visual Analog Score for pain Ratio Scale. Ratio Scale. ratio scale

Time frame: 2 years

25 patients were cured with comorbidity and 10 pateints died

ordinal scale Visual Analog Score for pain

Time frame: 2 years

pain

Visual Analog Score for pain

Time frame: two years

Secondary Outcomes

Visual Analog Score for pain

pain

Time frame: 2years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.